Показать сокращенную информацию
dc.contributor.author | Khaziakhmetova V. | |
dc.contributor.author | Miryakupova S. | |
dc.contributor.author | Dzhamalbekov A. | |
dc.contributor.author | Baiysbekov K. | |
dc.contributor.author | Torobekov S. | |
dc.contributor.author | Ziganshina L. | |
dc.date.accessioned | 2018-09-19T22:59:43Z | |
dc.date.available | 2018-09-19T22:59:43Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 2191-1630 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/145887 | |
dc.description.abstract | © 2016, Springer Science+Business Media New York.Prophylactic administration to rats with the model of chronic autoimmune inflammation, induced by Freund’s adjuvant, of a typical neuroleptic haloperidol at a dose of 0.1 mg/kg increased the intensity of the primary inflammatory response (arthritis) and inhibited progression of the secondary arthritis. | |
dc.relation.ispartofseries | BioNanoScience | |
dc.subject | Chronic autoimmune inflammation | |
dc.subject | Freund’s adjuvant | |
dc.subject | Haloperidol | |
dc.subject | Rats | |
dc.title | The Effects of Haloperidol on the Progression of Chronic Autoimmune Inflammation Induced by Freund’s Adjuvant | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 2 | |
dc.relation.ispartofseries-volume | 7 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 428 | |
dc.source.id | SCOPUS21911630-2017-7-2-SID85019101021 |